Advisory Services Network LLC Lowers Holdings in Chemours Co (NYSE:CC)

Advisory Services Network LLC decreased its holdings in Chemours Co (NYSE:CC) by 45.1% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,060 shares of the specialty chemicals company’s stock after selling 872 shares during the quarter. Advisory Services Network LLC’s holdings in Chemours were worth $39,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Cullen Frost Bankers Inc. acquired a new position in shares of Chemours during the first quarter valued at about $26,000. Zions Bancorporation N.A. acquired a new position in shares of Chemours during the first quarter valued at about $30,000. Enterprise Financial Services Corp raised its holdings in shares of Chemours by 306.5% during the first quarter. Enterprise Financial Services Corp now owns 935 shares of the specialty chemicals company’s stock valued at $34,000 after purchasing an additional 705 shares during the period. Legacy Bridge LLC raised its holdings in shares of Chemours by 100.0% during the first quarter. Legacy Bridge LLC now owns 1,200 shares of the specialty chemicals company’s stock valued at $45,000 after purchasing an additional 600 shares during the period. Finally, TCG Advisors LP acquired a new position in shares of Chemours during the first quarter valued at about $45,000. 80.36% of the stock is currently owned by institutional investors.

In other news, Director Bradley J. Bell acquired 5,000 shares of Chemours stock in a transaction on Thursday, May 16th. The stock was acquired at an average cost of $24.06 per share, with a total value of $120,300.00. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Mark P. Vergnano acquired 44,000 shares of Chemours stock in a transaction on Monday, June 10th. The stock was purchased at an average cost of $23.17 per share, with a total value of $1,019,480.00. Following the completion of the transaction, the chief executive officer now directly owns 116,600 shares in the company, valued at approximately $2,701,622. The disclosure for this purchase can be found here. Insiders acquired a total of 55,500 shares of company stock valued at $1,289,670 over the last ninety days. 2.34% of the stock is currently owned by insiders.

Several equities analysts have recently weighed in on CC shares. ValuEngine lowered shares of Zosano Pharma from a “buy” rating to a “hold” rating in a report on Wednesday, May 1st. Morgan Stanley restated an “overweight” rating on shares of in a report on Wednesday, June 19th. JPMorgan Chase & Co. restated an “overweight” rating and issued a $72.00 target price (up previously from $70.00) on shares of First Solar in a report on Monday, May 6th. SunTrust Banks began coverage on shares of Zillow Group in a report on Tuesday, July 9th. They issued a “buy” rating and a $49.39 target price on the stock. Finally, Jefferies Financial Group lowered their target price on shares of Chemours from $48.00 to $30.00 and set a “buy” rating on the stock in a report on Monday, June 10th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and six have given a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $38.10.

Shares of CC traded down $0.34 on Friday, reaching $18.81. The company’s stock had a trading volume of 2,397,097 shares, compared to its average volume of 2,848,930. The company has a quick ratio of 1.04, a current ratio of 1.81 and a debt-to-equity ratio of 5.18. Chemours Co has a twelve month low of $18.74 and a twelve month high of $48.97. The firm has a market cap of $3.14 billion, a PE ratio of 3.32, a PEG ratio of 0.32 and a beta of 2.50. The company has a fifty day moving average of $22.34.

Chemours (NYSE:CC) last issued its quarterly earnings data on Thursday, May 2nd. The specialty chemicals company reported $0.63 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.93 by ($0.30). Chemours had a return on equity of 87.75% and a net margin of 12.60%. The firm had revenue of $1.38 billion during the quarter, compared to the consensus estimate of $1.52 billion. During the same period in the previous year, the company posted $1.41 earnings per share. The company’s revenue for the quarter was down 20.5% on a year-over-year basis. Equities research analysts forecast that Chemours Co will post 3.92 EPS for the current fiscal year.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Fluoroproducts, and Chemical Solutions. The Titanium Technologies segment manufactures and sells titanium dioxide under the Ti-Pure and BaiMax brands for various applications in architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride window profiles, laminate papers used for furniture and building materials, and coated papers and paperboards used for packaging.

Featured Story: How Do You Calculate Return on Investment (ROI)?

Institutional Ownership by Quarter for Chemours (NYSE:CC)

Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.